Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2PX in post-amputation stump pain
NCT00592098Phase 2Completed
- Sponsor
- SantoSolve
- Start
- Aug 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Residual limb pain (RLP) comparing 2PX with Placebo (2 arms). Primary endpoint: Average Pain Intensity at 24 hours. Started Aug 2007; status: completed.
02
Drugs
strontium chloride hexahydrate
03
Conditions
Residual limb pain (RLP)
Beyond the preview
Go deeper on NCT00592098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592098.